American Cancer Society Journals shared a post on LinkedIn about a recent article by Angela N. Giaquinto et al., adding:
“A new American Cancer Society special report reveals that lobular breast cancer, or invasive lobular carcinoma (ILC), is on the rise for women in the United States.
Key findings:
- ~11% of U.S. breast cancers are ILC
- Incidence rising faster than other breast cancers
- ~33,600 U.S. diagnoses expected in 2025
- Tumors tend to be larger at diagnosis and have lower long-term survival in advanced cases
‘Our study underscores the need for much more information on lobular cancers across the board, from genetic studies to clinical trial data, so we can improve outcomes for the increasing number of women affected with this cancer,’ said Rebecca Siegel, MPH, senior scientific director of cancer surveillance research at the American Cancer Society and senior author of the study.
Next steps for research and care:
- Raise awareness of ILC’s unique clinical features
- Prioritize research on detection and treatment strategies
- Ensure equitable care and access across all breast cancer subtypes”
Title: Lobular breast cancer statistics, 2025
Authors: Angela N. Giaquinto, Rachel A. Freedman, Lisa A. Newman, Ahmedin Jemal, Rebecca L. Siegel
Read the Full Article on Cancer
More posts featuring American Cancer Society Journals
